Evaluation of alprazolam effect on tinnitus in the patients of Rasht Amiralmomenin Hospital
Phase 3
- Conditions
- Tinnitus.Tinnitus
- Registration Number
- IRCT138709121483N1
- Lead Sponsor
- Guilan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
1- Duration of tinnitus more than 1 year 2- Non pulsative tinnitus
Exclusion criteria:1- pulsative tinnitus 2- Meniere's disease 3- Vestibular Schwannoma 4-Otosclerosis 5-Hearing aid users 6- Temporal lobe tumor 7-Depression 8-Anxiety 9- Unable to tolerate minimal effective dose (0.5 mg Alprazolam bid)
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Tinnitus severity. Timepoint: at -3, 0, 8, 10, 18th week. Method of measurement: Tinnitus Handicap Inventory questionnaire.;Tinnitus test. Timepoint: at -3, 0, 8, 10, 18th week. Method of measurement: loudness matching.;Severity of Tinnitus. Timepoint: at -3, 0, 8, 10, 18th week. Method of measurement: Visual Analog Scale.
- Secondary Outcome Measures
Name Time Method